Symbol search
date o news sym
@MarketCurrents
09:58 Tue 4
Nws
$OMER - CDC and CMS OKs Omeros' ICD-10 codes for HSCT-TMA diagnosis and narsoplimab https://t.co/aCQrvgmHOp
-
https://seekingalpha.com/news/3689911-cdc-and-cms-oks-omeros-icd-10-codes-for-hsct-tma-diagnosis-and-narsoplimab?source=feed_f&utm_campaign=twitter_automated&utm_content=news&utm_medium=social&utm_source=twitter_automated
OMER
Healt
Text search
date o news
@MarketCurrents
09:58 Tue 4
Nws
$OMER - CDC and CMS OKs Omeros' ICD-10 codes for HSCT-TMA diagnosis and narsoplimab https://t.co/aCQrvgmHOp
-
OMER
Healt
@BBCWorld
13:13 Mon 3
Nws
Father buries 13-year-old son after his death in crush at Lag B'Omer festival in Israel https://t.co/3TVX8ry3rP https://t.co/HezoFPgE21
-


globenewswire
12:00 Tue 4
Nws
NetNumber Announces Availability of Application-to-Person (A2P) Text Messaging Capability
A2P tagging of 10 Digit Long Codes Support Critical to Delivering a Reliable Messaging channel for SMS Campaigns A2P tagging of 10 Digit Long Codes Support Critical to Delivering a Reliable Messaging channel for SMS Campaigns


prnewswire:443
10:21 Mon 3
SynGAP Research Fund and illumina Present 'Celebrating Caren,' the Incredible Story of the Oldest Known SYNGAP1 Patient in the United States
NEW YORK, May 3, 2021 /PRNewswire/ -- 64 years old at diagnosis, Caren is the oldest known person with SYNGAP1-related disorder in the United States. Today, May 3rd, Caren's 65th birthday, the SynGAP Research Fund (SRF) announces a new film about her remarkable life, family, and diagnosis...
ILMN
Healt
globenewswire
20:05 Tue 4
Nws
Exagen Inc., Allegheny Health Network Research Institute and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic Tests
The suite of innovative biomarker assays seeks to further aid clinicians in the diagnosis, prognosis and monitoring of patients with autoimmune diseases The suite of innovative biomarker assays seeks to further aid clinicians in the diagnosis, prognosis and monitoring of patients with autoimmune diseases
XGN
Healt
@InStyle
13:30 Wed 5
TrdId
Tess Holiday shared her anorexia nervosa diagnosis and already knows what you're thinking. https://t.co/Yz5kr59gpf
-


@InStyle
20:00 Wed 5
TrdId
'When I got the diagnosis, my first feeling was validation. The second was doubt. Don't these symptoms kind of desc https://t.co/yUycD470Ht
-


@InStyle
21:45 Mon 3
TrdId
Tess Holiday shared her anorexia nervosa diagnosis and already knows what you're thinking. https://t.co/XPdnLQmlJA
-


globenewswire
4h ago
Nws
With humor, insight, and charm, Annabelle Gurwitch shares her lung cancer journey on the Hope With Answers: Living With Lung Cancer Podcast
A stage four lung cancer diagnosis adds another line to Gurwitchs resume: lung cancer patient advocate with Lung Cancer Foundation of America A stage four lung cancer diagnosis adds another line to Gurwitchs resume: lung cancer patient advocate with Lung Cancer Foundation of America


@TheEconomist
17:23 Tue 4
Nws
Depressions diagnosis depends on a doctor's assessment, and can be subjective. This has led to a search for reliab https://t.co/hWB1YKZjI7
-


@CNBC
04:04 Tue 4
Nws
You may not be able to predict a breast cancer diagnosis, but you can prepare your finances for unexpected expenses https://t.co/ELXwfcb92J
-


@WHO
13:58 Wed 5
Nws
WHO is working actively to improve diagnosis and treatment for #asthma, particularly in low- and middle-income coun https://t.co/s5CW38Gdxk
-


@TheEconomist
01:57 Wed 5
Nws
Reliable biochemical markers of depression might assist diagnosis, improve assessments of prognosis and point towar https://t.co/VHBnXxYbEY
-


@business
01:52 Tue 4
TrdId
Asia's cultural triggers and Covid-era isolation make fertile ground for eating disorders. Diagnosis is poor and tr https://t.co/lG2aqvUnZy
-


@business
12:54 Mon 3
TrdId
Asia's cultural triggers and Covid-era isolation make fertile ground for eating disorders. Diagnosis is poor and tr https://t.co/WllA7TOFeT
-


marketwatch
6h ago
Dispatches from a Pandemic: Life turns on a dime: She donated $950 from her first stimulus check to a food bank then received a cancer diagnosis
After her financial circumstances changed, Toi Cudworth delayed payments on some loans, and bought frozen chicken and veggies because theyre cheaper and they last longer.


nytimes
09:00 Mon 3
Nws
Earlier Diabetes Onset Could Raise Dementia Risk
The younger the age at diagnosis for Type 2 diabetes, the higher the risk for Alzheimers disease and other forms of dementia years later.


prnewswire:443
14:48 Mon 3
Nws
Virtual Building Safety Month Celebration Begins
WASHINGTON, May 3, 2021 /PRNewswire/ -- Today marks the beginning of Building Safety Month, a campaign led by the International Code Council and its members and partners, to raise awareness about the importance of building codes and the role of building safety professionals in ensuring...


abcnews
19:50 Tue 4
N Carolina GOP advances bill to ban Down syndrome abortions
North Carolina Republican lawmakers have advanced a bill to make it illegal for physicians to perform abortions because of the fetus’ race or a prenatal diagnosis of Down syndrome


prnewswire:443
13:04 Mon 3
Nws
Cancer Survivor Cody O'Connor Announces 'Walk for Hope' to Raise Money for Pediatric Cancer Patients & Their Families
CINCINNATI, May 3, 2021 /PRNewswire/ -- After meeting 25-year-old Cody O'Connor from Cincinnati, you are sure to be inspired. Not only by his strength and resilience for having battled an Ewing's Sarcoma diagnosis at the age of 14, but for his determination to shine a light on the many...


forbes
21:21 Wed 5
Nws
Tatch Delivers The At-Home Diagnosis You Need For A Better Nights Sleep
Tatch is an at-home tool for diagnosing sleep disorders and helping people improve their restfulness in bed. We tested Tatch hands-on to see if it helps improve sleep health.


upi
13:45 Wed 5
Nws
Study: 'Prediabetes' raises risk for heart attack, stroke
Prediabetes -- where blood sugar levels are high, but not high enough for a diagnosis of type 2 diabetes -- significantly increases the risk of heart attack, stroke and other serious heart problems, new research shows.


prnewswire:443
16:30 Wed 5
Nws
First Light Diagnostics Appoints Joanne Spadoro as Chief Executive Officer
CHELMSFORD, Mass., May 5, 2021 /PRNewswire/ -- First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening antibiotic-resistant infections, has named Joanne Spadoro, PhD, as President and Chief Executive...


globenewswire
12:25 Mon 3
NwsFnnc
Exagen Announces New Campaign and Initiatives for Lupus Awareness Month
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- Exagen Inc.(Nasdaq: XGN),a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of awareness initiatives and educational tools highlighting the importance of an accurate and timely diagnosis and patient monitoring for Systemic Lupus Erythematosus (SLE).
XGN
Healt
prnewswire:443
17:56 Mon 3
Johnson Space Center Director Mark Geyer Moves To New Role
WASHINGTON, May 3, 2021 /PRNewswire/ -- Mark Geyer, director of NASA's Johnson Space Center, is stepping down from his position leading the center to focus more time on his health and family in light of a cancer diagnosis. 'Mark has had an exceptional impact on this agency, leading the...


proactiveinvestors
13:16 Tue 4
Versus Systems plans beta test of XEO fan engagement platform for Canelo Alvarez vs. Billy Joe Saunders title fight
Versus Systems Inc (NASDAQ:VS) (FRA:BMVB) announced plans to launch a beta test of XEO, its second screen gamified rewards platform, at the upcoming Canelo Alvarez vs. Billy Joe Saunders middleweight boxing title fight at AT&T Stadium in Dallas on May 8.   Versus is working with the marketing firm Frias Agency and Crush, the soda brand from Keurig Dr. Pepper (NASDAQ:KDP) (FRA:DP5).  XEO will allow Crush to create a unique engagement experience for fans watching the fight live, both in-stadium or watching on DAZN pay-per-view. More than 60,000 fans are expected to be in attendance, the company said, making the Canelo-Saunders fight the most-attended US sporting event since the coronavirus (COVID-19) shutdowns began in March 2020.  In the days leading up to the fight and during the fight itself, fans will be able to go to www.Crush-Canelo.com on their mobile devices and answer predictive questions about the weigh-in and the main event. They will also be able to play games and win daily prizes, including signed boxing gloves, DAZN codes and Crush soda. READ: Versus Systems engagement platform to include alcohol ads beginning in July Past Canelo fights have garnered more than 800,000 pay-per-view purchases, and his last televised fight in February 2021 had an audience of more than eight million TV viewers. We are thrilled to work with Crush and Canelo on this project, Versus CEO Matthew Pierce said in a statement. This beta test is an opportunity to showcase innovative brands, such as Crush, and to provide engaging content for millions of Canelo fans and boxing fans in general, both in-venue and at home.  A limited audience will also be invited to access the proprietary mobile engagement platform via a live URL and a QR code that will be revealed by Canelo Alvarez and Crush on social media this week. Those fans will be able to interact with Crush-sponsored content, prizes, event trivia and polling during the fight. The experience will be available online, as well as via Android and iOS mobile devices.   The Versus XEO platform makes it possible for brands like Crush to provide Canelo fans with a unique experience, giving brands real-time access to a captive audience while increasing viewership and creating memorable experiences for sports fans, Frias Agency CEO Andre Martelly said.  Frias is the marketing and experiential agency for brands and franchises including Crush, Modelo and Constellation Brands Inc (NYSE:STZ). Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com Follow him on Twitter @andrew_kessel
VRSSF
Commu
proactiveinvestors
02:33 Mon 3
Charlie Teo Foundation grant to fund key research of new Pharmaxis drug to tackle brain cancer
Pharmaxis Ltd (ASX:PXS) (FRA:UUD) drug discovery PXS-5505 will be the focus of a new study funded by a grant from the Charlie Teo Foundation, an Australian charity, for key research into a drug discovery tackling an aggressive and deadly form of brain cancer. The drug, PXS-5505, which has commenced a phase 1/2a clinical trial for the rare bone marrow cancer myelofibrosis, will now enter pre-clinical efficacy testing for glioblastoma (GBM), the most common form of brain cancer with an average survival of only 15 months from diagnosis. A$186,837 research grant Charlie Teo Foundation has awarded a A$186,837 research grant to Y Alan Wang, PhD, associate professor of Cancer Biology at The University of Texas MD Anderson Cancer Center to enable the study of PXS-5505. Pharmaxis CEO Gary Phillips said: We are delighted the Charlie Teo Foundation has awarded this grant to enable study of PXS-5505, aiming to fight this devastating form of brain cancer which is in desperate need of treatment options. 'I lost my own father to glioblastoma, so this project is close to my heart. 'We sincerely thank the Charlie Teo Foundation for recognising the potential for PXS-5505 and taking this last step to validate effectiveness.' Potent inhibitor Lysyl oxidase enzymes play a crucial role in GBM because they attract inflammatory cells that accelerate tumour growth and reduce survival. PXS-5505 is a potent inhibitor of lysyl oxidases and should stop these processes. Pharmaxis drug has demonstrated a good safety profile in healthy volunteer clinical studies in Australia. Previous research has already shown the importance of lysyl oxidases to tumour growth in GBM, and the current research will seek to validate the effectiveness of the Pharmaxis drug in brain cancer models. Phillips said: The study will run over one year and if successful can lead to clinical trials in 2022. This new project accesses external funds and expertise to extend the potential uses of PXS-5505 which is already entering efficacy trials in myelofibrosis, a rare form of bone marrow cancer, which is currently enrolling patients in a phase 1c/2 clinical trial. Worldwide, its estimated there are more than 300,000 cases of brain and nervous system tumours each year with GBM being the most common form (Lancet Neurol 2019). Out of the box thinking Charlie Teo Foundation founder and director Professor Charlie Teo said: As a neurosurgeon what I see most from my patients is shock and disbelief that there are no treatment options available to them. There is only one first-line chemotherapy and radiation therapy and these treatments only extend life by a matter of months. My brain cancer patients do not accept this fate, and neither do I.  Charlie Teo Foundation is bringing together teams who we consider to be the best brains around the globe, combining the necessary expertise with groundbreaking technology and out of the box thinking. Together, we believe we can improve treatment options for people with brain cancer. Funding brain cancer research Charlie Teo Foundation is an Australian charity dedicated to funding brain cancer research. Brain cancer kills more children in Australia than any other disease and more young people under 40 than any other cancer. The charity was officially launched by Professor Charlie Teo in March 2018, on the premise of running a low-cost charity and funding research differently. To date, Charlie Teo Foundation has raised more than $14 million for brain cancer research.